Bioreductive therapy.
Chaplin
D J
DJ
Tumour Biology Section, Xenova Limited, Slough, England.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015687:Cell Hypoxia; D006801:Humans; D008920:Misonidazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D009593:Nitroimidazoles / Q000627:therapeutic use; D010084:Oxidation-Reduction; D011355:Prodrugs / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D000077704:Tirapazamine; D014227:Triazines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009593:Nitroimidazoles; D011355:Prodrugs; D011838:Radiation-Sensitizing Agents; D014227:Triazines; C067834:RB 6145; D000077704:Tirapazamine; C041712:1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol; D008920:Misonidazole